AM
AMWL.US American Well Corp
- Market cap
- USD 202M
- P/E
- -
- P/B
- 0.98x
- ROE
- -20.3%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is AMWL.US undervalued?
Graham numberThe Graham number of American Well Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
American Well Corp fundamental analysis
No fundamental analysis for American Well Corp yet.
American Well Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About American Well Corp
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwe…
Full company profileAmerican Well Corp financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
American Well Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||
| Revenue | 114M | 149M | 245M | 253M | 277M | 259M | 254M | 249M | 208M |
| Gross Profit | 55.3M | 68.9M | 88.5M | 104M | 117M | 94.8M | 99.0M | 133M | 91.7M |
| Operating Income | -55.1M | -94.7M | -227M | -179M | -276M | -692M | -218M | -105M | -44.9M |
| EBITDA | -49.8M | -86.9M | -217M | -166M | -246M | -224M | -177M | -60.6M | -15.4M |
| Net Income | -52.7M | -87.2M | -224M | -176M | -270M | -675M | -208M | -95.7M | -42.9M |
| EPS | -26 | -42 | -45 | -14 | -20 | -48 | -14 | -5.96 | -2.51 |
| Balance Sheet | |||||||||
| Total Assets | 489M | 500M | 1.38B | 1.45B | 1.22B | 590M | 436M | 324M | 309M |
| Total Liabilities | 694M | 125M | 130M | 185M | 134M | 110M | 120M | 76.0M | 84.1M |
| Shareholders' Equity | 344M | 349M | 1.22B | 1.24B | 1.06B | 464M | 305M | 236M | 212M |
| Cash & Short-term Investments | 256M | 178M | 1.04B | 746M | 539M | 372M | 228M | 182M | 181M |
| Total Debt | - | 13.4M | 7.65M | 16.6M | 14.8M | 11.8M | 8.20M | 4.52M | 2.01M |
| Cash Flow | |||||||||
| Operating Cash Flow | -74.0M | -81.9M | -112M | -142M | -192M | -148M | -127M | -66.0M | -2.58M |
| Capital Expenditure | 1.91M | 1.34M | 3.32M | 559K | 10.4M | 15.2M | 15.2M | 21.0K | 7.43M |
| Free Cash Flow | -75.9M | -83.2M | -116M | -142M | -203M | -164M | -143M | -66.0M | -2.61M |
| Ratios | |||||||||
| ROE | -15.3% | -25.0% | -18.3% | -14.2% | -25.4% | -145.4% | -68.3% | -40.6% | -20.3% |
| ROA | -10.8% | -17.4% | -16.3% | -12.2% | -22.2% | -114.5% | -47.7% | -29.6% | -13.9% |
| Net Profit Margin | -46.2% | -58.6% | -91.5% | -69.8% | -97.6% | -260.6% | -81.8% | -38.4% | -20.6% |
| Debt to Equity | - | 0.04x | 0.01x | 0.01x | 0.01x | 0.03x | 0.03x | 0.02x | 0.01x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
American Well Corp dividends
American Well Corp has not paid dividends in the last 8 fiscal years.
Last stock split: 1:20 on Jul 11, 2024.
Who owns American Well Corp
- Insiders 4.51%
- Institutions 47.94%
- Public & others 47.56%
- Shares outstanding 15.6M
- Free float 12.2M
Top funds holding AMWL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 427K | 2.48% | 0.00% | Sep 2026 |
| Fidelity Extended Market Index | 69.6K | 0.40% | +34.79% | Sep 2026 |
| Russell Inv US Small Cap Equity Y | 69.5K | 0.40% | 0.00% | Sep 2026 |
| Dimensional US Small Cap ETF | 48.9K | 0.28% | 0.00% | Oct 2026 |
| Bridgeway Ultra-Small Company | 43.0K | 0.25% | 0.00% | Jun 2026 |
| iShares Micro-Cap ETF | 42.1K | 0.24% | 0.00% | Oct 2026 |
| Dunham Small Cap Value N | 29.4K | 0.17% | 0.00% | Sep 2026 |
| Fidelity Total Market Index | 28.6K | 0.17% | -0.06% | Sep 2026 |
| SEI Small Cap II A (SIIT) | 26.0K | 0.15% | 0.00% | Oct 2026 |
| Fidelity Series Total Market Index | 23.9K | 0.14% | 0.00% | Sep 2026 |
| Avantis US Small Cap Equity ETF | 19.5K | 0.11% | +0.42% | Oct 2026 |
| EA Bridgeway Ultra-Small Company Mkt ETF | 17.6K | 0.10% | 0.00% | Oct 2026 |
| Russell Inv US Small Cap Equity | 16.6K | 0.10% | 0.00% | Sep 2026 |
| DFA U.S. Small Cap I | 15.4K | 0.09% | 0.00% | Sep 2026 |
| DFA US Micro Cap I | 13.6K | 0.08% | 0.00% | Sep 2026 |
| DFA U.S. Vector Equity I | 9.26K | 0.05% | +9.90% | Sep 2026 |
| Invesco RAFI US 1500 Small-Mid ETF | 8.34K | 0.05% | 0.00% | Oct 2026 |
| Vanguard MStar Inst Ttl StkMktIdxInstlPl | 7.36K | 0.04% | 0.00% | Sep 2026 |
| Vanguard Balanced Index Inv | 7.23K | 0.04% | 0.00% | Sep 2026 |
| DFA US Social Core Equity 2 Portfolio | 4.90K | 0.03% | 0.00% | Sep 2026 |
Top institutions holding AMWL.US
| Holder | Shares | % of shares | Change | As of |
|---|---|---|---|---|
| RIMA MANAGEMENT, LLC | 1.33M | 7.72% | +16.94% | Jun 2026 |
| Morgan Stanley - Brokerage Accounts | 1.28M | 7.42% | +10.55% | Jun 2026 |
| Cable Car Capital LLC | 1.00M | 5.82% | 0.00% | Jun 2026 |
| Vanguard Capital Management, LLC | 611K | 3.55% | +7.75% | Jun 2026 |
| Acadian Asset Management LLC | 494K | 2.87% | +21.60% | Jun 2026 |
| BlackRock Inc | 428K | 2.48% | +9.25% | Jun 2026 |
| Renaissance Technologies Corp | 263K | 1.53% | +34.97% | Jun 2026 |
| Geode Capital Management, LLC | 159K | 0.92% | -15.79% | Jun 2026 |
| Two Sigma Investments LLC | 145K | 0.84% | +9.09% | Jun 2026 |
| Jane Street Group LLC | 141K | 0.82% | +161.09% | Jun 2026 |
| Rock Point Advisors, LLC | 134K | 0.78% | -1.27% | Jun 2026 |
| Dimensional Fund Advisors, Inc. | 132K | 0.77% | +7.73% | Sep 2026 |
| Marshall Wace Asset Management Ltd | 108K | 0.63% | +145.33% | Jun 2026 |
| Vanguard Fiduciary Trust Co | 91.3K | 0.53% | +14.18% | Jun 2026 |
| The Goldman Sachs Group Inc | 81.7K | 0.47% | -33.87% | Jun 2026 |
| State Street Corp | 56.6K | 0.33% | 0.00% | Jun 2026 |
| Lotus Technology Management, LP | 50.0K | 0.29% | 0.00% | Jun 2026 |
| UBS Group AG | 48.5K | 0.28% | +934.48% | Jun 2026 |
| Bridgeway Capital Management, LLC | 48.0K | 0.28% | 0.00% | Jun 2026 |
| HSBC Holdings PLC | 46.6K | 0.27% | 0.00% | Jun 2026 |
American Well Corp company profile
- Company name
- American Well Corp
- Ticker
- AMWL.US
- Exchange
- USA Stocks
- Listed since
- Sep 17, 2020
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 562
- Fiscal year end
- December
- Address
- 75 State Street, Boston, MA, United States, 02109
- Phone
- 617 204 3500
- Website
- business.amwell.com
About American Well Corp
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Amwell Platform, a cloud-based enablement platform, digitally enables a scalable healthcare experience across all care settings; Amwell Carepoint, a device enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings; Amwell Converge, a platform and wraparound services of digital care into the in-person, automated, and virtual care settings; and Behavioral Health, a platform that offer students and faculty the right level of care. It also provides specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members; Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.
American Well Corp management
8- Dr. Ido Schoenberg M.D.Chairman & CEO · born 1965
- Mr. Mark J. Hirschhorn CPAExecutive VP, COO & CFO · born 1965
- Mr. Dan ZamanskyChief Product & Technology Officer · born 1984
- Mr. Paul Francis McNeiceVice President of Accounting · born 1977
- Anna NesterovaHead of Legal & Deputy General Counsel
- Mr. Michael MillerSenior Vice President & Chief Sales Officer
- Ms. Phyllis I. GotlibPresident of Amwell International · born 1958
- Dr. Cynthia Horner FAAFP, M.D.Chief Medical Officer & President of Amwell Medical Group